Data from one of Pear Therapeutics' key deals is driving conversations about how...
MK-0616 is a peptide commercialized by Merck, with a leading Phase III program i...
The company will suspend the development of three assets, considering strategic ...
We interviewed Datwyler’s Gabrielle Gehron to understand the best sourcing strat...
European Commission has approved the oral combination drug for treating newly di...
The company plans to refile the IND after assessing the feasibility of US FDA-su...
Pelican Technology has combined business with Primordial Genetics under a deal t...
Orexo has submitted a new drug application (NDA) to the US FDA for its high-dose...
BioNTech has entered a strategic collaboration with the CEPI to develop mRNA-bas...
UK-based Pharmanovia has announced the acquisition of 11 central nervous system ...
Puxitatug Samrotecan is a monoclonal antibody conjugated commercialized by Astra...
The FTC and DOJ got a flood of comments urging them to adopt their proposed merg...
Chamber and government lawyers sparred over whether drugmakers have enough say i...
Online services may be enormously beneficial for people with substance use disor...
Medicare plans to pay more for a type of cardiac rehabilitation that takes place...
Advocates want to expand the use of midwives in childbirth and diversify the mid...
